Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.21.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Concentration Risk [Line Items]        
Revenues $ 93,105 $ 74,329 $ 281,600 $ 234,509
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 71,271 59,748 222,223 185,971
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 21,834 $ 14,581 $ 59,377 $ 48,538